Trump-EU Trade Deal Could Hit Pharmaceutical Industry with Billions in New Costs

The trade deal between the U.S. and the European Union is set to impose a 15% tariff on U.S.-bound imports of branded drugs from Europe, potentially costing the industry between $13 billion and $19 billion. This development threatens to drive up prices and limit access to essential medications for Americans. The pharmaceutical industry, which has relied heavily on foreign countries' manufacturing and raw materials, will now face significant new costs due to the tariffs.

Key Takeaways:

• The trade deal could cost the pharmaceutical industry between $13 billion and $19 billion due to the imposition of a 15% tariff on U.S.-bound imports of branded drugs from Europe.
• Ireland is the largest source of branded pharmaceuticals for the U.S., accounting for approximately $50 billion of imports last year.
• Key pharmaceutical companies, such as Pfizer and Johnson & Johnson, have made Ireland a significant manufacturing hub and source of cancer drugs, insulin, and other essential medications.
• The tariffs will affect items like packaging and plastics used for bottles or blister packs, potentially influencing the cost of low-priced generics and over-the-counter products made in the EU.
• The pharmaceutical industry will need to reassess its manufacturing and cost structures due to the tariffs, potentially leading to increased prices and limited access to essential medications for Americans.

Statistics:

• $50 billion: The value of U.S. pharmaceutical imports from Ireland last year (Source: Reuters)
• $13 billion - $19 billion: The estimated cost of the tariffs to the pharmaceutical industry (Source: Reuters, Axios)
• 15%: The tariff rate imposed on U.S.-bound imports of branded drugs from Europe
• 200%: The tariff rate threatened by President Trump on pharmaceutical imports (Source: Axios)

Sources:

• Reuters: "EU-US trade deal could add up to $19bln to pharma industry costs, analysts say"
• Axios: Original article
• Reuters: "Widely used drugs in US imports from Europe"
• CNBC: "Trump tariffs trade lawsuits"